Growing community of inventors

Bellevue, WA, United States of America

Joseph Naemura

Average Co-Inventor Count = 4.71

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 205

Joseph NaemuraPeter S Linsley (9 patents)Joseph NaemuraRobert Peach (9 patents)Joseph NaemuraJurgen Bajorath (9 patents)Joseph NaemuraChristian P Larsen (2 patents)Joseph NaemuraThomas C Pearson (2 patents)Joseph NaemuraAndrew B Adams (2 patents)Joseph NaemuraJean-Claude Becker (1 patent)Joseph NaemuraDavid Hagerty (1 patent)Joseph NaemuraRobert Cohen (1 patent)Joseph NaemuraSuzette Carr (1 patent)Joseph NaemuraJoseph Naemura (9 patents)Peter S LinsleyPeter S Linsley (77 patents)Robert PeachRobert Peach (43 patents)Jurgen BajorathJurgen Bajorath (23 patents)Christian P LarsenChristian P Larsen (6 patents)Thomas C PearsonThomas C Pearson (3 patents)Andrew B AdamsAndrew B Adams (2 patents)Jean-Claude BeckerJean-Claude Becker (11 patents)David HagertyDavid Hagerty (9 patents)Robert CohenRobert Cohen (8 patents)Suzette CarrSuzette Carr (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bristol-myers Squibb Compnay (9 from 3,681 patents)


9 patents:

1. 10370428 - Methods of treatment using CTLA4 mutant molecules

2. 9758565 - Methods of treatment using CTLA4 mutant molecules

3. 8785398 - Methods of treatment using CTLA4 mutant molecules

4. 7829534 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

5. 7700556 - Methods of treatment using CTLA4 mutant molecules

6. 7455835 - Methods for treating immune system diseases using a soluble CTLA4 molecule

7. 7439230 - Methods of treatment using CTLA4 mutant molecules

8. 7304033 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

9. 7094874 - Soluble CTLA4 mutant molecules

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…